Radiation With Chemotherapy and a Study Drug to the Para-Aortic Nodes in Cervical Cancer

Investigator has since decided not to pursue this protocol further. No patients were enrolled. This study is to determine the maximum tolerated dose of external beam radiation to the para-aortic lymph nodes using intensity modulated radiation therapy (IMRT). This protocol will test the hypothesis that the use of IMRT and amifostine will decrease GI toxicity and therefore allow the radiation dose to the para-aortic lymph nodes to be safely escalated.

Sex

Female

Minimum age

19 Years

Inclusion Criteria:

* No prior therapy other than biopsy of the cervix or endoscopic pelvic nodal resection.
* Patients may have endoscopic resection of enlarged pelvic and low common iliac nodes, however, needle biopsy only of enlarged para-aortic nodes will be eligible for entry.
* Patients with squamous cell, adenocarcinoma, and adenosquamous carcinoma are eligible.
* Patients must have no evidence of metastatic disease outside of the pelvis (except to the para-aortic nodes).
* Patients must have Zubrod performance status 0-1 and no medical contraindications to the administration of full dose chemotherapy.
* Patients must have a life expectancy \> 6 months
* Adequate bone marrow function: white blood cell (WBC) 3000/mm3 (absolute neutrophil count \[ANC\] 1500/mm3); adequate renal function: creatinine 1.5 mg/dl (urinary diversion is permitted to improve renal function); patients must have bilirubin 1.5 mg/dl, ALT 2 x normal.
* No prior (within last 3 years) or simultaneous malignancies (other than basal cell or non-invasive tumors)

Exclusion Criteria:

* Complete resection of the involved para-aortic nodes.
* Patients with evidence of bowel adherent to the GTV by contrast enhanced computed tomography (CT) scan will be ineligible.
* Patients with the following histologies will be ineligible: glassy cell, small cell, carcinoid, adenoid cystic, and clear cell.
* Prior (within last 3 years) malignancies other than basal cell carcinoma or non-invasive malignancies.
* Prior chemotherapy.
* Prior pelvic or abdominal radiation (other than transvaginal irradiation to control bleeding).
* Prior tumor-directed surgery other than lymph node sampling/staging
* Life expectancy \< 6 months
* Patients who are pregnant will be ineligible.
* Patients with insulin dependent diabetes will be ineligible.
* Patients who are obese, such that reliable immobilization is not achieved.
* Patients with pain or discomfort that would preclude lying still for extended periods of time.
* Patients with tumors that are bleeding and require more immediate treatment.

• BACKGROUNDGrigsby PW, Heydon K, Mutch DG, Kim RY, Eifel P. Long-term follow-up of RTOG 92-10: cervical cancer with positive para-aortic lymph nodes. Int J Radiat Oncol Biol Phys. 2001 Nov 15;51(4):982-7. doi: 10.1016/s0360-3016(01)01723-0. PMID 11704321
• BACKGROUNDBerman ML, Keys H, Creasman W, DiSaia P, Bundy B, Blessing J. Survival and patterns of recurrence in cervical cancer metastatic to periaortic lymph nodes (a Gynecologic Oncology Group study). Gynecol Oncol. 1984 Sep;19(1):8-16. doi: 10.1016/0090-8258(84)90151-3. PMID 6469092
• BACKGROUNDLepanto P, Littman P, Mikuta J, Davis L, Celebre J. Treatment of para-aortic nodes in carcinoma of the cervix. Cancer. 1975 Jun;35(6):1510-3. doi: 10.1002/1097-0142(197506)35:63.0.co;2-u. PMID 807311
• BACKGROUNDLovecchio JL, Averette HE, Donato D, Bell J. 5-year survival of patients with periaortic nodal metastases in clinical stage IB and IIA cervical carcinoma. Gynecol Oncol. 1989 Jul;34(1):43-5. doi: 10.1016/0090-8258(89)90103-0. PMID 2737524
• BACKGROUNDNori D, Valentine E, Hilaris BS. The role of paraaortic node irradiation in the treatment of cancer of the cervix. Int J Radiat Oncol Biol Phys. 1985 Aug;11(8):1469-73. doi: 10.1016/0360-3016(85)90334-7. PMID 4019270
• BACKGROUNDTewfik HH, Buchsbaum HJ, Latourette HB, Lifshitz SG, Tewfik FA. Para-aortic lymph node irradiation in carcinoma of the cervix after exploratory laparotomy and biopsy-proven positive aortic nodes. Int J Radiat Oncol Biol Phys. 1982 Jan;8(1):13-8. doi: 10.1016/0360-3016(82)90378-9. PMID 7061247
• BACKGROUNDGrigsby PW, Perez CA, Chao KS, Herzog T, Mutch DG, Rader J. Radiation therapy for carcinoma of the cervix with biopsy-proven positive para-aortic lymph nodes. Int J Radiat Oncol Biol Phys. 2001 Mar 1;49(3):733-8. doi: 10.1016/s0360-3016(00)00806-3.